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CA125

:   carbohydrate antigen 125

CA19‐9
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CD31

:   cluster of differentiation 31

CD34

:   cluster of differentiation 34

CT

:   computed tomography

IgG4

:   immunoglobulin G4

IVC

:   inferior vena cava

IVLCH

:   intravenous lobular capillary hemangioma

MRI

:   magnetic resonance imaging

sIL‐2R

:   soluble interleukin‐2 receptor

Keynote messageThis is the first report of intravenous lobular papillary hemangioma originated from right ovarian vein and extended to inferior vena cava. Its etiology and clinical characteristics are reviewed based on literature search.

Introduction {#iju512043-sec-0005}
============

Lobular capillary hemangioma, also known as pyogenic granuloma, is a benign vascular tumor of the skin and mucosal membranes. Intravenous pyogenic granuloma also known as IVLCH is the intravascular counterpart of pyogenic granuloma, first reported by Cooper *et al*.[1](#iju512043-bib-0001){ref-type="ref"} The pathogenesis of IVLCH remains unclear, with a neoplastic process favored.[2](#iju512043-bib-0002){ref-type="ref"} Herein, we report a case with IVLCH originated from right ovarian vein, extending to IVC and mimicking a tumor thrombus.

Case presentation {#iju512043-sec-0006}
=================

A 66‐year‐old female visited our department on account of shadow defect in vena cava of right renal hilum appeared on CT for periodically checking 3 years after radical hysterectomy with bilateral ovariectomy. Abdominal CT identified a shadow defect of 35 mm in diameter in the IVC continuing posteriorly to a 35 mm mass of retroperitoneum (Fig. [1](#iju512043-fig-0001){ref-type="fig"}). Physical examination revealed no mass in the abdomen. The results of complete blood count, chemistry, and urinalysis were all within the normal including carcinoembryonic antigen, CA19‐9, CA125, neuron‐specific enolase, sIL‐2R, and IgG4. The mass showed an early phase strong enhancement followed by a delayed enhancement. By the abdominal MRI, the tumor showed a high signal intensity at T2‐weighted images and slightly high signal at the diffusion‐weighted images. The laboratory and image diagnosis indicated a tumor of vascular origin. However, we could not exclude angiosarcoma or tumor thrombus originated from prior cancer; therefore, we performed a tumor removal. During the surgery, we identified an intravascular tumor of dumbbell like shape presenting in right ovarian vein extending to IVC. With the aid of vascular surgeon, we removed the mass together with the wall of ovarian vein and IVC. The defect of IVC was closed by using a graft of saphenous vein. Though we prepared extracorporeal circulation before surgery, the temporary blocking of IVC beneath the renal veins derived no reduction of blood pressure and we did not use the equipment.

![Contrast‐enhanced computed tomographic image. Abdominal CT identified a shadow defect of 35 mm in diameter in the IVC continuing posteriorly to a 35 mm mass of retroperitoneum (yellow arrows). Red arrowheads indicate right ovarian vein.](IJU5-2-80-g001){#iju512043-fig-0001}

Microscopically, the tumor consisted of microcapillaries which formed reticular structure. Though the endothelial cells of them were relatively dense, there was no atypical cell or mitotic cell (Fig. [2](#iju512043-fig-0002){ref-type="fig"}). Immunostaining of specimens identified positive CD31, CD34, and Factor 8 in all cells. Ki67 antibody was positive at 2--3% of all cells (Fig. [2](#iju512043-fig-0002){ref-type="fig"}). These findings suggested the tumor was intravenous lobular papillary hemangioma. One year after surgery, she experiences no recurrence or new lesion of the tumor (Figs [3](#iju512043-fig-0003){ref-type="fig"},[4](#iju512043-fig-0004){ref-type="fig"}).

![Plain MRI. MRI identifies an intracaval mass with a high signal intensity at T2‐weighted image and a slightly high signal at the diffusion‐weighted image (yellow arrowheads).](IJU5-2-80-g002){#iju512043-fig-0002}

![Macroscopic appearance of mass during surgery. A red and soft mass of 35 mm in diameter is identified in the IVC continuing posteriorly to a 35 mm mass of retroperitoneum (yellow arrowhead).](IJU5-2-80-g003){#iju512043-fig-0003}

![Pathological findings. Microscopically, the tumor consisted of microcapillaries which formed reticular structure. Though the endothelial cells of them were relatively dense, there was no atypical cell or mitotic cell. Immunostaining of specimens identified positive CD31, CD34, and Factor 8 in all cells. Ki67 antibody was positive at 2--3% of all cells.](IJU5-2-80-g004){#iju512043-fig-0004}

Discussion {#iju512043-sec-0007}
==========

A PubMed search by using (*intravascular* or *intravenous) pyogenic granuloma* or *hemangioma,* and *intravascular lobular capillary hemangioma* following the selection, we obtained 74 cases among 38 reports (Table [S1](#iju512043-sup-0001){ref-type="supplementary-material"}). According to these reports, the median age of this entity is 50 years old (range 3--75) with the male to female ratio of 2:3. The median size of lesion is 15 mm (range 4--85). Most of these tumors originated from the wall of veins of head and neck (33%), upper and lower extremity (28%), unknown (24%) and various miscellaneous veins including thoracic (*n* = 2), renal (*n* = 2), ovarian (*n* = 2), mesenteric (*n* = 1), azygos (*n* = 1), iliac (*n* = 1), and corpus carvenosum (*n* = 1). One case with renal vein and present case with ovarian vein extended to IVC.

As precedent disease, 87% of cases accompanied no description, 9% had trauma or surgery, 3% inflammation, and 1% deep vein thrombosis. The patient of present case had a history of right ovariectomy and this might have induced IVLCH.

Nine of 38 reports described its prognosis. Based on 10 cases with a median observation period of 1 year (0.5--7 years) only one case suffered from recurrence. These data indicate that it is a benign disease which shows favorable response for the surgical treatment.

In conclusion, we report a case of lobular capillary hemangioma in the right ovary vein. This is the first report of intravenous lobular papillary hemangioma originated from right ovarian vein extended to IVC.
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